Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
about
Management of antipsychotic-related weight gainSchizophrenia: a multisystem disease?Cytokines in Schizophrenia: Hope or Hype?Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidityBetter understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse modelsFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismMeta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effectsChronic Psychosocial Stress Impairs Bone Homeostasis: A Study in the Social Isolation Reared Rat.Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients.The risk of diabetes in deficit schizophreniaElevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective studyProlactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosis.Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis.Metabolome in schizophrenia and other psychotic disorders: a general population-based study.Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia."Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder.Screening for substance use disorders in first-episode psychosis: implications for readmission.Schizophrenia: a systemic disorderStem cell signaling in newly diagnosed, antipsychotic-naive subjects with nonaffective psychosis.Metabolic effects of olanzapine in patients with newly diagnosed psychosis.Neurobiology of schizophrenia onset.Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.Interventions for the metabolic syndrome in schizophrenia: a reviewPotential metabolite markers of schizophrenia.Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary viewPrevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depressionAbnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathwaySerum and gene expression profile of cytokines in first-episode psychosis.A significant causal association between C-reactive protein levels and schizophreniaThe prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.Schizophrenia as a systemic diseaseThe Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?
P2860
Q24610124-118F1E43-41AE-4D6A-872C-C1C2D967570DQ24633845-4B3F6F4D-2CD3-4994-8F3A-B9DD4D5CB8EBQ26750430-8F12B243-A492-479A-A0CD-DC1C4BBD044EQ26752342-87586FFE-3C1A-4351-876A-B930B1FDFDC2Q26866254-15B5AAAD-FC2B-46B4-9668-60CFFEC53A33Q28067617-AA9D3E56-65BB-40AF-AA9A-53B3BC5D369DQ28657600-CE2A7053-BF03-4C53-9095-257E229E4FC2Q30380187-7D718635-7C59-4D69-B340-1E82E48C90D0Q33845034-7E7090AE-16EA-48F7-B661-9734BCAD704AQ33846109-F3DD7170-F8FD-4212-9833-C25282DA140AQ34048554-5E2C09D0-7AC7-4994-8961-FDF69306B148Q34289021-1284C259-3F95-4299-9CC1-AC2AE0DE1CCCQ34289026-BFF7069C-CD1A-4AC3-986D-0E49D50EDFB8Q34289039-ED601670-158B-4756-A93B-B04C5C0E3A7DQ34971495-A95DC0CB-63D1-4A95-8549-2365261AFCCBQ35230391-939C52B1-146A-4A39-A842-4E69830AA99DQ35323821-917F868E-BF21-4A1A-8FA1-29F2F828082FQ35323897-2EB6C02C-85E8-4C91-BB2F-2F2AB12B51C3Q35323907-0DB93CBC-319C-4A1B-AE1F-5293DB7130A2Q35323916-B135F945-6445-4B45-A697-65FEB28D9197Q35323981-35715A42-8872-4482-8C51-426E8A13F0A9Q35660832-EB44A582-254A-4304-A396-0CCC08E6F818Q35768175-E1D64BCE-8783-42E3-9E00-530D90B62A8CQ36031032-0A27D0D2-A681-4958-8BEB-094C88084CC2Q36138754-93F580D9-DD2A-4E99-830A-8AA233B46362Q36168604-0992A9E5-BCDB-4C90-952E-2D62C41FA281Q36401248-9802BBB7-24A0-4CB2-AB42-28E82A5023DEQ36479055-27C0E25C-332F-4746-856B-6226253A0B6DQ36621014-3AC8D340-2303-4058-BF0F-962626422600Q36621075-3EDE41C8-7943-4069-A597-125F0DBF6F05Q36653387-AE33E415-A28B-4530-BBDA-E6B75C657D6FQ36835108-206393C8-21DD-4793-9F0E-B73109410CACQ36910378-81F30D21-8A06-4F6F-8810-DCC424A5096DQ36914697-5BFEF2ED-04CE-4208-B3F7-759F21060642Q37079080-E13D7A66-1EC7-4E81-AC02-EC6AFA8535F8Q37102229-53D80233-228C-448A-AD13-2B04B3A8CA1DQ37137023-F7116269-6B17-40E4-818E-AE3B67DE8C4CQ37137037-8F8975C1-9C83-4B42-AFF1-7AFF464DF48BQ37637480-7560C60B-7614-40B8-AE57-01A96B226AFAQ37721268-F263A1BD-FC11-47C3-AA8D-75F7560C2B2F
P2860
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
@en
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.
@nl
type
label
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
@en
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.
@nl
prefLabel
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
@en
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.
@nl
P2093
P2860
P1476
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
@en
P2093
Azucena Justicia
Clemente Garcia-Rizo
Eduard Parellada
Emilio Fernandez-Egea
Enric Esmatjes
Ignacio Conget
Miguel Bernardo
Thomas Donner
P2860
P304
P356
10.1192/BJP.BP.108.052605
P407
P577
2009-05-01T00:00:00Z